Predicting circulating CA125 levels among healthy premenopausal women

BACKGROUND: CA125 is the most promising ovarian cancer screening biomarker to date. Multiple studies reported CA125 levels vary by personal characteristics, which could inform personalized CA125 thresholds. However, this has not been well described in premenopausal women. METHODS: We evaluated predi...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Cancer Epidemiol Biomarkers Prev
المؤلفون الرئيسيون: Sasamoto, Naoko, Babic, Ana, Rosner, Bernard A., Fortner, Renée T., Vitonis, Allison F., Yamamoto, Hidemi, Fichorova, Raina N., Tjønneland, Anne, Hansen, Louise, Overvad, Kim, Kvaskoff, Marina, Fournier, Agnès, Romana Mancini, Francesca, Boeing, Heiner, Trichopoulou, Antonia, Peppa, Eleni, Karakatsani, Anna, Palli, Domenico, Pala, Valeria, Mattiello, Amalia, Tumino, Rosario, Grasso, Chiara C., Onland-Moret, N. Charlotte, Weiderpass, Elisabete, Quirós, J. Ramón, Lujan-Barroso, Leila, Rodríguez-Barranco, Miguel, Colorado-Yohar, Sandra, Barricarte, Aurelio, Dorronsoro, Miren, Idahl, Annika, Lundin, Eva, Sartor, Hanna, Khaw, Kay-Tee, Key, Timothy J, Muller, David, Riboli, Elio, Gunter, Marc J., Dossus, Laure, Kaaks, Rudolf, Cramer, Daniel W., Tworoger, Shelley S., Terry, Kathryn L.
التنسيق: Artigo
اللغة:Inglês
منشور في: 2019
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548604/
https://ncbi.nlm.nih.gov/pubmed/30948451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-18-1120
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة